Format

Send to

Choose Destination
Br J Pharmacol. 2016 Feb;173(3):601-12. doi: 10.1111/bph.13391. Epub 2016 Jan 14.

The high frequency relationship: implications for torsadogenic hERG blockers.

Author information

1
Centre de Recherches Biologiques, CERB, Chemin de Montifault, 18800, Baugy, France.
2
Laboratoire PHYMEDEXP, Physiologie et Médecine Expérimentale, Cœur et Muscles, INSERM U1046, CNRS UMR 9214, Université de Montpellier, CHU Arnaud de Villeneuve, 371 Avenue du doyen G. Giraud, 34295, Montpellier cedex 05, France.

Abstract

BACKGROUND AND PURPOSE:

Ventricular arrhythmias induced by human ether-a-go-go related gene (hERG; Kv 11.1 channel) blockers are a consequence of alterations in ventricular repolarisation in association with high-frequency (HF) oscillations, which act as a primary trigger; the autonomic nervous system plays a modulatory role. In the present study, we investigated the role of β1 -adrenoceptors in the HF relationship between magnitude of heart rate and QT interval changes within discrete 10 s intervals (sorted into 5 bpm heart rate increments) and its implications for torsadogenic hERG blockers.

EXPERIMENTAL APPROACH:

The HF relationship was studied under conditions of autonomic blockade with atenolol (β1 -adrenoceptor blocker) in the absence or presence of five hERG blockers in beagle dogs. In total, the effects of 14 hERG blockers on the HF relationship were investigated.

KEY RESULTS:

All the torsadogenic hERG blockers tested caused a vertical shift in the HF relationship, while hERG blockers associated with a low risk of Torsades de Pointes did not cause any vertical shift. Atenolol completely prevented the effects four torsadogenic agents (quinidine, thioridazine, risperidone and terfenadine) on the HF relationship, but only partially reduced those of dofetilide, leading to the characterization of two types of torsadogenic agent.

CONCLUSIONS AND IMPLICATIONS:

Analysis of the vertical shift in the HF relationship demonstrated that signs of transient sympathetic activation during HF oscillations in the presence of torsadogenic hERG blockers are mediated by β1 -adrenoceptors. We suggest the HF relationship as a new biomarker for assessing Torsades de pointes liability, with potential implications in both preclinical studies and the clinic.

PMID:
26589499
PMCID:
PMC4728413
DOI:
10.1111/bph.13391
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center